Characterization of Nanoparticle Tracking Analysis for Quantification and Sizing of Submicron Particles of Therapeutic Proteins
- 1 August 2015
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 104 (8) , 2441-2450
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (RO1 EB006006-01)
This publication has 20 references indexed in Scilit:
- Evaluation of nanoparticle tracking analysis for total virus particle determinationVirology Journal, 2012
- Issues and Challenges of Subvisible and Submicron Particulate Analysis in Protein SolutionsThe AAPS Journal, 2012
- Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking AnalysisNanomedicine: Nanotechnology, Biology and Medicine, 2011
- Classification and Characterization of Therapeutic Antibody AggregatesJournal of Biological Chemistry, 2011
- Development of high concentration protein biopharmaceuticals: The use of platform approaches in formulation developmentEuropean Journal of Pharmaceutics and Biopharmaceutics, 2011
- Strategies for the Assessment of Protein Aggregates in Pharmaceutical Biotech Product DevelopmentPharmaceutical Research, 2010
- Measuring number‐concentrations of nanoparticles and viruses in liquids on‐lineJournal of Chemical Technology & Biotechnology, 2010
- An Industry Perspective on the Monitoring of Subvisible Particles as a Quality Attribute for Protein TherapeuticsJournal of Pharmaceutical Sciences, 2010
- Critical Evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the Measurement of Nanoparticles and Protein AggregatesPharmaceutical Research, 2010
- Overlooking Subvisible Particles in Therapeutic Protein Products: Gaps That May Compromise Product QualityJournal of Pharmaceutical Sciences, 2009